Amia Capital LLP Intercept Pharmaceuticals, Inc. Transaction History

Amia Capital LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $283,328 - $558,406	-6,067 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $77,891 - $191,193	-1,611 Reduced 20.98%	6,067 $382,000
Q4 2019 Feb 13, 2020	BUY	$57.36 - $124.1 $440,410 - $952,839	7,678 New	7,678 $951,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

Stay updated on Amia Capital LLP with notifications on news.